Having authored hundreds of publications, the Pentara team has significant experience and specialized knowledge in:
Neurodegenerative Diseases
- Alzheimer's Disease
- Parkinson’s Disease
- Vascular Dementia
- Amyotrophic Lateral Sclerosis (ALS)
- Duchenne Muscular Dystrophy
- Huntington’s Disease
- Hyperphagia
- Spinocerebellar Ataxia
- Friedreich’s Ataxia
- Facioscapulohumoral Muscular Dystrophy (FSHD)
- Frontotemporal Disorder (FTLD)
- Biomarker Research
Psychiatry & Central Nervous System (CNS) Disorders
- Bipolar Disorder
- Borderline Personality Disorder
- Agitation/Aggression in Alzheimer’s Disease
- Other - Psychiatry and CNS
Rare Diseases
- Dravet Syndrome
- Duchenne Muscular Dystrophy
- Leukodystrophies
- Encephalopathies
- Galactosemia
- Netherton Syndrome
- Cushing's Syndrome
- CMT-SORD
- Facioscapulohumoral Muscular Dystrophy (FSHD)
- Spinocerebellar Ataxia
- Friedreich’s Ataxia
- Amyotrophic Lateral Sclerosis (ALS)
- Frontotemporal Disorder (FTLD)
Cancer
- Primary Myelofibrosis (PMF)
- Post-polycythemia Vera Myelofibrosis (Post-PV MF)
- Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
- Acute Myeloid Leukemia (AML) - Relapsed or Refractory
- Multiple Myeloma (RRMM) - Relapsed or Refractory
Healthspan/Anti-aging Research
- Intrinsic Capacity (IC)
- Alzheimer's Prevention Research